1. Congenital myasthenic syndrome caused by a frameshift insertion mutation in
- Author
-
Szabolcs, Szelinger, Jonida, Krate, Keri, Ramsey, Samuel P, Strom, Perry B, Shieh, Hane, Lee, Newell, Belnap, Chris, Balak, Ashley L, Siniard, Megan, Russell, Ryan, Richholt, Matt De, Both, Ana M, Claasen, Isabelle, Schrauwen, Stanley F, Nelson, Matthew J, Huentelman, David W, Craig, Samuel P, Yang, Steven A, Moore, Kumaraswamy, Sivakumar, Vinodh, Narayanan, and Sampathkumar, Rangasamy
- Subjects
Article - Abstract
Objective Description of a new variant of the glutamine-fructose-6-phosphate transaminase 1 (GFPT1) gene causing congenital myasthenic syndrome (CMS) in 3 children from 2 unrelated families. Methods Muscle biopsies, EMG, and whole-exome sequencing were performed. Results All 3 patients presented with congenital hypotonia, muscle weakness, respiratory insufficiency, head lag, areflexia, and gastrointestinal dysfunction. Genetic analysis identified a homozygous frameshift insertion in the GFPT1 gene (NM_001244710.1: c.686dupC; p.Arg230Ter) that was shared by all 3 patients. In one of the patients, inheritance of the variant was through uniparental disomy (UPD) with maternal origin. Repetitive nerve stimulation and single-fiber EMG was consistent with the clinical diagnosis of CMS with a postjunctional defect. Ultrastructural evaluation of the muscle biopsy from one of the patients showed extremely attenuated postsynaptic folds at neuromuscular junctions and extensive autophagic vacuolar pathology. Conclusions These results expand on the spectrum of known loss-of-function GFPT1 mutations in CMS12 and in one family demonstrate a novel mode of inheritance due to UPD.
- Published
- 2019